Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic ResponsesJacopo Canzian, Alberto Zambelli, Fabio Conforti et al.|Cancers|2025Cited by 23
Superior Survival and Lower Recurrence Outcomes with Breast-Conserving Surgery Compared to Mastectomy Following Neoadjuvant Therapy in 607 Breast Cancer PatientsDamiano Gentile, Corrado Tinterri, Jacopo Canzian et al.|Cancers|2025Cited by 11
Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment responseJacopo Canzian, Rita De Sanctis, Flavia Jacobs et al.|Critical Reviews in Oncology/Hematology|2025Cited by 5
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapyFlavia Jacobs, Rita De Sanctis, Mariangela Gaudio et al.|The Oncologist|2025Cited by 5
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologistsMariangela Gaudio, Alberto Zambelli, Giulia Vatteroni et al.|Critical Reviews in Oncology/Hematology|2025Cited by 2